Fenfluramine HCl (Fintepla ® ) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

Fenfluramine HCl Provides Long-Term Clinically Meaningful Reduction in Seizure Frequency: Results of an Open-Label Extension Study

(2020) Sameer Zuberi et al.   EPILEPSY & BEHAVIOR

Impact of CYP2C19 phenotypes on clinical efficacy of stiripentol in Japanese patients with Dravet syndrome

(2019) Yoshiaki Yamamoto et al.   THERAPEUTIC DRUG MONITORING

Long‐term efficacy of add‐on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study

(2019) Anna Rosati et al.   EPILEPSIA

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

(2019) Lieven Lagae et al.   LANCET

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens

(2019) Rima Nabbout et al.   JAMA Neurology

Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study

(2018) Kenneth A Myers et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors

(2018) María Rodríguez-Muñoz et al.   Oncotarget

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

(2018) Orrin Devinsky et al.   EPILEPSIA

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors

(2017) Cynthia Harden et al.   NEUROLOGY

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis

(2016) Igho J. Onakpoya et al.   CRITICAL REVIEWS IN TOXICOLOGY

Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine

(2016) Berten Ceulemans et al.   EPILEPSIA

Mortality in Dravet syndrome: A review

(2016) Sharon Shmuely et al.   EPILEPSY & BEHAVIOR

Mortality in Dravet syndrome

(2016) Monica S. Cooper et al.   EPILEPSY RESEARCH

Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients

(2016) A. Schoonjans et al.   EUROPEAN JOURNAL OF NEUROLOGY

The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome

(2015) Luis Miguel Aras et al.   EPILEPSY & BEHAVIOR

Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome

(2015) An-Sofie Schoonjans et al.   Therapeutic Advances in Neurological Disorders

Successful use of fenfluramine as an add-on treatment for Dravet syndrome

(2012) Berten Ceulemans et al.   EPILEPSIA

The core Dravet syndrome phenotype

(2011) Charlotte Dravet   EPILEPSIA

A long-term follow-up study of Dravet syndrome up to adulthood

(2009) Mari Akiyama et al.   EPILEPSIA